Barbara Bohle Selected Research

Barbara Bohle Research Topics

Disease

59	Hypersensitivity (Allergy) 03/2024 - 01/2002
22	Seasonal Allergic Rhinitis (Hay Fever) 01/2023 - 11/2002
17	Food Hypersensitivity (Food Allergy) 08/2022 - 03/2004
6	Inflammation (Inflammations) 01/2022 - 11/2004
3	Atopic Dermatitis (Atopic Eczema) 06/2008 - 05/2004
2	Pneumonia (Pneumonitis) 01/2023 - 05/2018
2	Asthma (Bronchial Asthma) 01/2022 - 05/2018
2	Infections 01/2022 - 01/2021
2	Leukemia 10/2017 - 03/2010
2	Immediate Hypersensitivity 02/2011 - 12/2003
2	Anaphylaxis (Anaphylactic Shock) 01/2011 - 04/2003
2	Skin Diseases (Skin Disease) 07/2005 - 05/2004
1	Polyps 10/2023
1	Autoimmune enteropathy 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Allergic Rhinitis 01/2022
1	Dust Mite Allergy 03/2021
1	Neoplasms (Cancer) 01/2021
1	Rupture 10/2020
1	Blister (Bulla) 01/2019
1	Granuloma 05/2006
1	Eosinophilia 04/2006
1	Hyperhomocysteinemia 12/2003
1	Rheumatoid Arthritis 07/2002

Drug/Important Bio-Agent (IBA)

63	AllergensIBA 03/2024 - 01/2002
29	Immunoglobulin E (IgE)IBA 03/2024 - 04/2003
15	Proteins (Proteins, Gene)FDA Link 10/2023 - 06/2004
13	VaccinesIBA 03/2021 - 06/2004
10	AntibodiesIBA 01/2024 - 07/2005
8	CytokinesIBA 01/2022 - 05/2004
7	Peptides (Polypeptides)IBA 01/2022 - 11/2002
4	Immunoglobulin G (IgG)IBA 01/2024 - 03/2011
4	EpitopesIBA 01/2022 - 02/2005
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2019 - 07/2005
3	Interleukin-4 (Interleukin 4)IBA 10/2023 - 07/2009
3	Immunoglobulins (Immunoglobulin)IBA 06/2021 - 11/2004
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2018 - 01/2011
3	AntigensIBA 05/2018 - 11/2002
2	LigandsIBA 01/2022 - 01/2013
2	Interleukin-33IBA 06/2021 - 07/2014
2	Recombinant ProteinsIBA 01/2018 - 03/2005
2	AutoantibodiesIBA 06/2008 - 07/2005
2	AutoantigensIBA 06/2008 - 07/2002
1	InterleukinsIBA 10/2023
1	Chemokine ReceptorsIBA 10/2023
1	Monoclonal AntibodiesIBA 01/2022
1	ProlaminsIBA 01/2022
1	TropomyosinIBA 01/2022
1	Antimicrobial PeptidesIBA 01/2022
1	Glutens (Glutelin)IBA 01/2022
1	Single-Domain AntibodiesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Complement System Proteins (Complement)IBA 06/2021
1	Blocking AntibodiesIBA 10/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2020
1	aluminum sulfate (alum)IBA 10/2020
1	Interleukin-3 (Interleukin 3)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Codon (Codons)IBA 01/2018
1	FlagellinIBA 01/2018
1	Profilins (Profilin)IBA 10/2017
1	DisulfidesIBA 10/2017
1	SolutionsIBA 08/2017
1	A-factor (Streptomyces)IBA 01/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013
1	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 08/2012
1	EndotoxinsIBA 02/2011
1	PyrogensIBA 02/2011
1	GlobulinsIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 03/2010
1	Histocompatibility Antigens Class IIIBA 03/2010
1	Pru p 3 allergenIBA 07/2009
1	integrin beta7IBA 07/2009
1	Interleukin-2 (IL2)IBA 07/2009
1	Interleukin-10 (Interleukin 10)IBA 07/2009
1	ragweed pollenIBA 06/2009
1	nascent-polypeptide-associated complexIBA 06/2008
1	DNA (Deoxyribonucleic Acid)IBA 08/2007
1	LatexIBA 08/2006
1	lipid transfer protein (glycolipid transfer protein)IBA 08/2006
1	OligonucleotidesIBA 02/2005
1	NucleotidesIBA 02/2005
1	Recombinant Fusion ProteinsIBA 06/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2003
1	HomocysteineIBA 12/2003
1	OligodeoxyribonucleotidesIBA 05/2003
1	Analgesics (Analgesic Drugs)IBA 04/2003
1	propyphenazoneIBA 04/2003
1	pyrazoloneIBA 04/2003
1	CPG-oligonucleotideIBA 11/2002
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 07/2002
1	Filaggrin ProteinsIBA 07/2002

Therapy/Procedure

26	Immunotherapy 11/2023 - 01/2002
5	Therapeutics 01/2022 - 03/2004
2	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2024 - 01/2011
1	Oral Administration 01/2017